SCHEMBL29989503

SCHEMBL29989503

CC(F)(F)c1ncc(Br)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.33
KMT2A Q03164 3/20 0.32
HTT P42858 1/20 0.32
MEN1 O00255 2/20 0.32
IDH1 O75874 2/20 0.31
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31
NT5E P21589 1/20 0.31
MET P08581 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31
PLA2G1B P04054 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31
HSD11B1 P28845 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29268175 1.00 PLAU (0.40) PLAUSMN1; SMN2KMT2AHTTMEN1
SCHEMBL16654525 0.89 PLAU (0.40) PLAUSMN1; SMN2KMT2AHTTMEN1
SCHEMBL21718921 0.84 PLAU (0.42) PLAUSMN1; SMN2KMT2AHTTMEN1
SCHEMBL15674757 0.84 PLAU (0.42) PLAUSMN1; SMN2KMT2AHTTNT5E
SCHEMBL16654936 0.81 PLAU (0.35) PLAUALDH1A1MAPT
SCHEMBL16664998 0.81 PLAU (0.38) PLAUKMT2AHTTMEN1S1PR1
SCHEMBL25206015 0.81 PLAU (0.43) PLAUSMN1; SMN2KMT2AHTTMEN1
SCHEMBL29818360 0.81 PLAU (0.43) PLAUSMN1; SMN2KMT2AHTTMEN1
SCHEMBL21994706 0.81 PLAU (0.40) PLAUSMN1; SMN2KMT2AHTTS1PR1
SCHEMBL22770846 0.80 S1PR1 (0.36) SMN1; SMN2KMT2AHTTMEN1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081653-A2 METHODS OF LOWERING MIRO2 TO TREAT NEURODEGENERATIVE DISEASES ACUREX BIOSCIENCES CORPORATION (US) 2024-04-18 WO disclosed
EP-4301759-A2 T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF The Board of Trustees of the Leland Stanford Junior University (US) 2024-01-10 EP disclosed
CN-116917289-A T-type calcium channel antagonists and uses thereof 小利兰·斯坦福大学董事会 2023-10-20 CN disclosed
WO-2022216386-A9 T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-12-01 WO disclosed
WO-2022216386-A2 T-TYPE CALCIUM CHANNEL ANTAGONISTS AND USES THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-10-13 WO disclosed